Simplex Trading’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-8,093
| Closed | -$13K | – | 9918 |
|
|
2025
Q2 | $11K | Sell |
8,093
-4,688
| -37% | -$6.12K | ﹤0.01% | 7261 |
|
|
2025
Q1 | $12K | Sell |
12,781
-5,578
| -30% | -$6.72K | ﹤0.01% | 6992 |
|
|
2024
Q4 | $24K | Buy |
18,359
+16,111
| +717% | +$48K | ﹤0.01% | 6547 |
|
|
2024
Q3 | $7K | Sell |
2,248
-1,676
| -43% | -$5.52K | ﹤0.01% | 7455 |
|
|
2024
Q2 | $12K | Sell |
3,924
-1,353
| -26% | -$4.83K | ﹤0.01% | 7319 |
|
|
2024
Q1 | $24K | Sell |
5,277
-5,276
| -50% | -$33.8K | ﹤0.01% | 6958 |
|
|
2023
Q4 | $77K | Sell |
10,553
-8,745
| -45% | -$48.9K | ﹤0.01% | 5643 |
|
|
2023
Q3 | $233K | Buy |
19,298
+13,621
| +240% | +$141K | ﹤0.01% | 4191 |
|
|
2023
Q2 | $60K | Buy |
5,677
+4,692
| +476% | +$48.3K | ﹤0.01% | 5649 |
|
|
2023
Q1 | $9K | Sell |
985
-5,812
| -86% | -$66.7K | ﹤0.01% | 7648 |
|
|
2022
Q4 | $99K | Buy |
6,797
+6,775
| +30,795% | +$101K | ﹤0.01% | 5090 |
|
|
2022
Q3 | $0 | Sell |
22
-1,298
| -98% | -$16.7K | ﹤0.01% | 10748 |
|
|
2022
Q2 | $18K | Buy |
1,320
+1,285
| +3,671% | +$15.1K | ﹤0.01% | 7731 |
|
|
2022
Q1 | $0 | Sell |
35
-265
| -88% | -$3.93K | ﹤0.01% | 11251 |
|
|
2021
Q4 | $6K | Buy |
+300
| New | +$7.07K | ﹤0.01% | 9430 |
|
Simplex Trading's RPTX Position: Q3 2025 in Review
Simplex Trading sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 8,093 shares — an estimated $13K sold.
Simplex Trading first reported a position in RPTX in Q4 2021 and held it in 15 quarters. The position peaked at $233K in Q3 2023. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.
- Simplex Trading reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 8,093 Repare Therapeutics shares in Q3 2025, an estimated $13K.
- Simplex Trading first reported a position in Repare Therapeutics in Q4 2021 and held it in 15 quarters.
- Simplex Trading's Repare Therapeutics position peaked at $233K in Q3 2023.
- 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.